HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuro Kumeda Selected Research

Glycemic Control

3/2022Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes.
3/2019Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profiles.
11/2015Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuro Kumeda Research Topics

Disease

7Hypoglycemia (Reactive Hypoglycemia)
03/2022 - 11/2015
6Type 2 Diabetes Mellitus (MODY)
01/2024 - 10/2008
6Diabetes Mellitus
03/2022 - 06/2002
3Cardiovascular Diseases (Cardiovascular Disease)
03/2009 - 12/2005
3Hypothyroidism
02/2007 - 01/2005
3Atherosclerosis
12/2005 - 11/2003
2Arteriosclerosis
05/2023 - 08/2006
2Diabetes Complications
05/2023 - 05/2008
2Bone Resorption
05/2008 - 04/2008
2Body Weight (Weight, Body)
02/2007 - 09/2005
2Vascular System Injuries
01/2005 - 02/2004
2Arthritis (Polyarthritis)
12/2003 - 12/2002
1Fatty Liver
05/2023
1Dyslipidemias (Dyslipidemia)
05/2023
1Polycythemia (Erythrocytosis)
03/2023
1Hydronephrosis
03/2023
1Urinary Calculi (Urinary Calculus)
03/2023
1Hypoxia (Hypoxemia)
03/2023
1Neoplasms (Cancer)
03/2023
1Weight Gain
03/2022
1Cardiac Arrhythmias (Arrythmia)
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022
1Heart Failure
01/2022
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2022
1Secondary Hyperparathyroidism
01/2021
1Hypoalbuminemia
08/2019
1Chronic Kidney Failure (Chronic Renal Failure)
11/2015
1Chronic Thyroiditis
03/2009
1Osteoporosis
05/2008
1Hyperglycemia
05/2008
1Graves Disease (Basedow Disease)
09/2007
1Hyperthyroidism
09/2007
1Anemia
03/2007
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2005
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2005
1Inflammation (Inflammations)
11/2003
1Inappropriate ADH Syndrome (SIADH)
12/2002

Drug/Important Bio-Agent (IBA)

7Glucose (Dextrose)FDA LinkGeneric
01/2024 - 11/2015
5Insulin Glargine (Lantus)FDA Link
01/2024 - 03/2019
5AlbuminsIBA
01/2022 - 09/2005
5Indicators and Reagents (Reagents)IBA
10/2008 - 11/2003
4insulin degludecIBA
01/2024 - 03/2019
4Insulin (Novolin)FDA Link
01/2022 - 08/2006
3Thyroxine (Levothyroxine)FDA LinkGeneric
12/2005 - 11/2003
2ErythropoietinFDA Link
03/2023 - 03/2007
2Blood Glucose (Blood Sugar)IBA
01/2022 - 08/2006
2Phosphates (Orthophosphate)IBA
02/2007 - 09/2005
2Parathyroid Hormone (Parathormone)IBA
09/2005 - 06/2002
1LiraglutideFDA Link
01/2024
1lixisenatideIBA
01/2024
1LipidsIBA
05/2023
11,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA
05/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2023
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
05/2023
1EnzymesIBA
05/2023
1Alanine Transaminase (SGPT)IBA
05/2023
1IDegLiraIBA
01/2022
1insulin glulisineFDA Link
01/2022
1Nonesterified Fatty Acids (NEFA)IBA
01/2022
1etelcalcetide hydrochlorideIBA
01/2021
1maxacalcitolIBA
01/2021
1Calcium-Sensing ReceptorsIBA
01/2021
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2021
16- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
12/2020
1ipragliflozinIBA
12/2020
1Biomarkers (Surrogate Marker)IBA
08/2019
1Serum AlbuminIBA
08/2019
1InsulinsIBA
03/2019
13- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
11/2015
1Sorbitol (Yal)FDA Link
05/2008
1Tartrate-Resistant Acid PhosphataseIBA
04/2008
1OsteocalcinIBA
04/2008
1collagen type I trimeric cross-linked peptideIBA
04/2008
1Alkaline PhosphataseIBA
04/2008
1Collagen Type I (Type I Collagen)IBA
04/2008
1Immunoglobulin E (IgE)IBA
09/2007
1LDL CholesterolIBA
09/2007
1Methimazole (Thiamazole)FDA LinkGeneric
09/2007
1Triglycerides (Triacylglycerol)IBA
09/2007
1oxidized low density lipoproteinIBA
09/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2007
13-FT (3 FT)IBA
09/2007
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2007
1C-Reactive ProteinIBA
02/2007
1Proteins (Proteins, Gene)FDA Link
02/2007
1AdiponectinIBA
12/2005
1AdipokinesIBA
12/2005
1ThrombomodulinIBA
12/2005
1MagnesiumIBA
11/2005
1von Willebrand FactorIBA
01/2005
1Thyroid HormonesIBA
02/2004
1Alendronate (Alendronate Sodium)FDA LinkGeneric
12/2003
1CreatinineIBA
11/2003
1CalciumIBA
11/2003
1CholesterolIBA
11/2003
1Vasopressins (Vasopressin)IBA
12/2002

Therapy/Procedure

6Therapeutics
03/2022 - 12/2005
4Renal Dialysis (Hemodialysis)
01/2021 - 03/2007
3Glycemic Control
03/2022 - 11/2015
2Injections
03/2022 - 11/2019